Treviño-Nakoura, Ana
Sepúlveda-Crespo, Daniel
Bellon, José M
Codina, Helena
Quero-Delgado, Marta
Ryan, Pablo
Martínez, Isidoro
Resino, Salvador https://orcid.org/0000-0001-8783-0450
Funding for this research was provided by:
Instituto de Salud Carlos III (PI20CIII/00004, PI19CIII/00009, PI23CIII/00018, CP23CIII/00004)
Gilead Sciences (GLD20_0144)
Centro de Investigación Biotecnológica en Red de Enfermedades Infecciosas (CB21/13/00044)
Article History
Received: 1 October 2024
Accepted: 21 November 2024
First Online: 2 December 2024
Declarations
:
: This study was approved by the “Instituto de Salud Carlos III” Ethics Committee (Ref.: CEI PI 13_2021). This study involves clinical-epidemiological data of the patients from the published articles, so the informed consent signed by the patients was unnecessary.
: Not applicable.
: The authors declare that they have no competing interests.